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554 The Journal of Thoracic and CardioBackground: Donor-specific tolerance to organ allografts might be induced by
cotransplantation of a sufficient amount of vascularized donor thymus. To facilitate
donor thymus–induced cardiac allograft tolerance, we have developed a novel
technique for heart and en-bloc thymus transplantation in swine.
Methods: Donor heart and en-bloc thymus grafts were prepared by a technique that
preserves the entire arterial supply and venous drainage of the right thymic lobe.
En-bloc grafts (n 4) were transplanted heterotopically into the abdomens of major
histocompatibility complex–matched miniature swine. Recipients received 12 days
of cyclosporine intravenously. Grafts were monitored by palpation, electrocardio-
graphic monitoring, and periodic open biopsy. Engraftment of the donor thymus was
demonstrated by measuring the proportion of recipient-type thymocytes in the donor
thymus with flow cytometry.
Results: All of the heart and en-bloc thymus grafts had normal cardiac contractility
and immediate perfusion of the thymus. All en-bloc grafts were accepted for more
than 200 days without significant acute cellular rejection or cardiac allograft
vasculopathy. Thymic tissue of en-bloc grafts displayed normal architecture and
supported thymopoiesis of recipient-type cells.
Conclusion: We have validated a new technique of donor thymus transplantation
that could have utility in human heart transplantation.
T he thymus prevents autoimmunity through a variety of mechanisms, includ-ing the negative selection of autoreactive T lymphocytes and the creation ofregulatory T lymphocytes.1 These thymic functions are also important in the
establishment of robust donor-specific tolerance in the transplant setting.2 Indeed,
transplantation of donor thymus tissue results in donor-specific tolerance capable of
prolonging cardiac allograft survival.3 Previously, thymic transplantation techniques
in large animals depended on either pretransplantation modification of the donor
organ by implantation of thymic tissue to create a composite graft (thymoheart or
thymokidney) or on microsurgical techniques to transplant a vascularized thymic
lobe.4,5 We sought to develop a clinically relevant technique to confer large amounts
of donor thymus to the recipient of a cardiac allograft at the time of organ
transplantation. To that end, we developed an en-bloc technique that permits the
cotransplantation of the heart and immediately vascularized thymus. This report
describes our novel technique.
Methods
Animals
Heart and en-bloc thymus grafts were procured from and transplanted between animals
belonging to partially inbred, major histocompatibility complex (MHC)–defined lines of
Massachusetts General Hospital (MGH) miniature swine bearing mismatches only in minor
histocompatibility antigens.6 Recipients were chosen that were positive for a PAA or CD4
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are detectable with available monoclonal antibodies.7 All animal
care and procedures were in compliance with the “Principles of
Laboratory Animal Care” formulated by the National Society for
Medical Research and the “Guide for the Care and Use of Labo-
ratory Animals” (NRC 1996); all animal experiments were ap-
proved by the Massachusetts General Hospital Subcommittee on
Research and Animal Care.
Heart and En-bloc Thymus Harvest
The pig has 2 prominent cervical thymic lobes in addition to the
mediastinal thymic lobes. Thymic vascular anatomy is very vari-
able. Anatomic studies in various mammalian species suggest that
thymic arterial supply and venous drainage are not predictable and
are based on multiple branches.8,9 In this experiment the right
cervical and mediastinal thymic lobes were harvested en bloc with
the heart, which allowed the preservation of all arterial and venous
branches to the thymus (Figure 1). The donor was placed in the
supine position, and a midline cervical incision and sternotomy
were performed. The sternohyoid and sternothyroid muscles were
divided at their sternal attachments and retracted cephalad. The
right carotid artery and internal jugular vein were isolated at the
level of the cricothyroid membrane. The axillary artery and vein
were isolated over the first rib. The left carotid artery (which arises
from the innominate artery in the pig) was isolated approximately
3 cm distal to its origin. The left innominate vein was ligated and
divided at the confluence of the internal jugular and axillary veins.
The azygos vein was ligated at its origin from the superior vena
cava. The right internal thoracic artery and internal thoracic vein
were ligated and divided approximately 3 cm from their origins
and were mobilized with care to preserve fine branches to the
mediastinal thymus. The inferior vena cava (IVC) was isolated.
The donor was systemically heparinized (200 U/kg), and all iso-
lated vessels were ligated. The IVC was ligated and divided,
permitting the heart to decompress. Cardioplegic solution (Pleg-
isol; Abbott Laboratories, North Chicago, Ill) was administered
through a catheter placed either in the aortic root or the left carotid
stump, with a crossclamp applied to the aorta distal to the origin of
the innominate artery and proximal to the origin of the left axillary
artery (the clavicle is absent in pigs). After the heart was arrested
and cardioplegic solution was delivered for 5 minutes, the heart
and en-bloc thymus graft were dissected free of remaining attach-
ments, the pulmonary veins were divided, the pulmonary artery
was divided at its bifurcation, and the aorta was divided distal to
the crossclamp. An atrial septal defect was created if not already
present, and the small left atrial defect was repaired with a running
suture (6-0 Prolene; Ethicon Inc, Somerville, NJ). The pulmonary
veins and IVC were ligated.
Heterotopic Heart and En-bloc Thymus
Transplantation
The recipient was placed in the supine position and had 2 indwell-
ing lines placed in the external jugular veins. A midline laparotomy
was performed, and the infrarenal aorta and IVC were isolated. After
systemic heparinization (200 U/kg), the donor pulmonary artery was
anastomosed in end-to-side fashion to the IVC with a continuous
6-0 Prolene suture. Next the donor aorta was anastomosed end to
side to the recipient aorta in similar fashion. Before abdominal
The Journal of Thoraciclosure, 2 iridium-tipped electrodes were implanted into the epi-
cardium of each ventricle and brought out through the flank for
long-term electrocardiographic monitoring.
Postoperative Monitoring and Immunosuppression
Graft viability was confirmed by daily abdominal palpation of the
beating heart.10 Animals received cyclosporine (INN: ciclosporin)
at a dose of 10 to 13 mg · kg1 · d1 intravenously for 12 days,
starting on the day of transplantation. Cyclosporine doses were
adjusted to achieve serum trough levels of 400 to 800 ng/mL. The
heart and thymus were biopsied serially through a laparotomy and
submitted for histologic analysis through hematoxylin and eosin
Figure 1. Miniature swine heart and en-bloc thymus graft. The
vasculature of the en-bloc graft is depicted with respect to the
right cervical and mediastinal thymic lobes. R.C.T., Right cervical
thymus; R.M.T., right mediastinal thymus; LCC, left common ca-
rotid artery; RCC, right common carotid artery; LIV, left innominate
vein; P.A., pulmonary artery; RITA, right internal thoracic artery;
RITV, right internal thoracic vein; RAV, right axillary vein; RAA,
right axillary artery; RIJ, right internal jugular vein; IVC, inferior
vena cava.stain and van Gieson elastin stain.
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Barium was perfused into the aortic arch of one such heart and
en-bloc thymus graft to visualize the thymic vasculature. Histo-
logic examinations of sections of cervical thymus, mediastinal
thymus, and myocardium were performed to detect barium in the
small arteries.
Assessment of Thymopoiesis
Thymic allografts were assessed both histologically and by flow
cytometry. Repopulation of the donor thymus by recipient thymo-
TABLE 1. Survival of MHC-matched heart and en-bloc
thymus grafts
Animal Allograft
Strain
combination Survival (d)*
15168 Heart and en-bloc thymus HH ¡ HH 274
15165 Heart and en-bloc thymus HH ¡ HH 206
15228 Heart and en-bloc thymus DD ¡ DD 277
15256 Heart and en-bloc thymus DD ¡ DD 227
MHC, Major histocompatibility complex. *All animals were put to death
Figure 2. Arterial anatomy of heart and en-bloc thymus
the anterior view of the heart, right cervical thymu
arrowhead). B, Arterial angiography of en-bloc graft pe
(Ao). En-bloc dissection involves preservation of the i
artery (3), thyrocervical trunk (4), and right internal th
cervical (black arrowhead) and thoracic (white arro
superior vena cava (6). C, Hematoxylin and eosin–stain
small arteries, confirming perfusion.with the heart beating.
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antibody. Biopsies of the thymus were obtained serially at the time
of heart biopsy. Thymic tissue was submitted for routine histologic
study and was also processed by manual disruption and gradient
separation (lymphocyte separation media; Organon Teknika,
Durham, NC) to isolate thymocytes. Thymocytes were resus-
pended in flow cytometry medium (Hanks balanced salt solution,
0.1% bovine serum albumin, and 0.1% NaN3) and stained with
monoclonal antibodies specific for either the recipient CD4 allele
(clone 74-12-4, IgG2b) or PAA allele (clone 1038H-10-9, IgM)
and nonallelic CD1 (clone 76-7-4, IgG2a) for 30 minutes at 4°C.11
After washing, stained cells were analyzed on a FACScan (Becton
Dickinson, San Jose, Calif).
Results
Heart and En-bloc Thymus Transplantation
A barium angiogram of a heart and en-bloc thymus graft
(Figure 2, A) was performed, revealing the thymic vascular
anatomy and preservation of fine thymic arterial branches
(Figure 2, B). Histologic analysis revealed the presence of
barium in the small arterial vessels of all sections of thymus
examined, as well as the myocardium (Figure 2, C). On
fts. A, Gross specimen of en-bloc graft with display of
lack arrowhead), and right thoracic thymus (white
ed by means of infusion of barium into the aortic root
inate artery (1), right carotid artery (2), right axillary
ic artery (5), as well as fine thymic branches to the
d) thymic lobes. Venous return is visualized in the
ymus and heart revealed the presence of barium in thegra
s (b
rform
nnom
orac
whea
ed threperfusion of en-bloc grafts, the thymuses immediately
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equate venous drainage.
Survival
Four consecutive heart and en-bloc thymus transplantations
were performed between minor mismatched MGH minia-
ture swine to test the long-term thympoietic function of the
transplanted thymic grafts. After a short course of cyclo-
sporine, all hearts survived indefinitely, and animals were
put to death with the heart beating 200 days after transplan-
tation (Table 1).
Graft Histology
Only 1 of the 4 heart grafts had any evidence of acute
rejection (seen at 12 weeks, International Society for Heart
and Lung Transplantation grade 2/4), which resolved before
the next biopsy performed at 24 weeks after transplantation.
There was no evidence of acute rejection at postmortem
examination of all 4 hearts (Figure 3, A). Early biopsy
specimens (4 weeks after transplantation) of all 4 thymic
allografts revealed viable and normal-appearing thymic tis-
sue on histopathology (Figure 3, B). Later biopsy specimens
of each thymic graft showed evidence of focal thymic
atrophy and fibrous replacement. However, some normal-
appearing thymic tissue was identified in all en-bloc grafts.
Although allograft rejection cannot be absolutely ruled out,
the focal histologic changes seen in the thymus likely rep-
resent a response to injury from the multiple biopsies.
Thymic involution is observed in normally aging miniature
swine as well, although this is typically a diffuse and
generalized process, unlike what was observed in the thymic
grafts.
Although this study was not designed to assess the ef-
fects of donor thymic transplantation on the host allore-
sponse, evaluation for chronic rejection of the cardiac allo-
grafts, as assessed by morphometric analysis, showed no
Figure 3. Histology of heart and en-bloc thymus graft t
(H&E)–stained heart without evidence of acute rejectio
0/4). B, Hematoxylin and eosin–stained thymus revealin
corpuscle (white box and C).significant incidence of cardiac allograft vasculopathy in all
The Journal of Thoraci4 en-bloc grafts (data not shown). Furthermore, these or-
gans were maintained without significant acute or chronic
rejection for more than 200 days without additional im-
munosuppression beyond the initial 12-day course of
cyclosporine.
Recipient Thymopoiesis in Grafts
The function of transplanted thymic tissue was assessed by
measuring recipient thymopoiesis in donor thymus grafts.
Transplantations were performed between animals that dif-
fered in either CD4 or PAA alleles; recipient CD4 or PAA
alleles were detectable with allele-specific monoclonal an-
tibodies. Flow cytometry revealed increasing numbers of
recipient-type thymocytes (CD1) in the donor thymus
graft that reached proportions similar to those in the native
thymus by 90 days after transplantation, as shown in 2
representative animals (Figure 4). The majority of cells
isolated from the donor thymus were CD4/CD8 double
positive and CD1 positive, confirming that they were thy-
mocytes (data not shown). Furthermore, the normal propor-
tion of recipient thymocytes in the donor thymus graft
persisted for the duration of analysis (Figure 4), indicating
that thymopoiesis was ongoing at the time animals were put
to death. Parenthetically, peripheral blood mononuclear
cells were isolated from recipients of en-bloc allografts, and
macrochimerism was assessed by flow cytometry. Although
low levels of donor-type lymphocytes were detected in the
recipient’s peripheral blood mononuclear cells initially after
thymus transplantation, their levels quickly diminished with
time, indicating that mixed chimerism was not established
(data not shown).
Discussion
Although vascularized thymic transplantation has been per-
formed in rodents by en-bloc harvest of the heart and
ted for more than 200 days. A, Hematoxylin and eosin
ternational Society for Heart and Lung Transplantation
mal cortical and medullary architecture and a Hassalsolera
n (In
g northymus,12 there have been no descriptions of a clinically
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tation. We have established a new surgical technique that
makes harvesting heart and en-bloc thymus grafts possible
in large animals and human subjects. The heart and en-bloc
thymus graft allows for immediate communication between
the immune system of the host and the vascularized donor
thymic tissue. Although tolerance has been achieved by
grafting nonvascularized allogeneic thymic tissue into a
variety of host sites in immunodeficient mice,13 efforts to
cotransplant nonvascularized thymic tissue at the time of
organ transplantation as a means of inducing tolerance in
large animals have been unsuccessful. This might be due to
rejection and loss of the thymic graft before the establish-
ment of adequate vascularization. Indeed, the ischemic pe-
riod in the first 1 to 3 weeks leads to temporary loss of the
thymic graft structure, which is reconstituted over the next
5 to 7 weeks.14 During this period of revascularization, there
is increased susceptibility to nonspecific graft loss and an
increased potential for sensitization of the recipient.
We demonstrated that the heart and en-bloc thymus graft
was capable of supporting thymopoiesis. It is hypothesized
that thymopoiesis that occurs in the donor thymus will
involve deletion of donor-specific T lymphocytes, genera-
tion of regulatory T lymphocytes, and development of an
otherwise normal T-cell repertoire necessary for immuno-
competence.5 Alternatively, thymic engraftment seen in
these animals might be a consequence of tolerance induced
Figure 4. Recipient-type thymopoiesis in thymus grafts. Monoclo-
nal antibody specific for either recipient CD4 or PAA allele was
used to follow thymopoiesis of recipient cells in the donor thymus
graft. Recipient thymocytes, CD4CD1 or PAACD1 double-pos-
itive cells, reached levels in the donor thymus comparable with
levels seen in the native recipient thymus by postoperative day 100.
Data from 2 animals are shown, which are representative.by the short course of cyclosporine.
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thymic cotransplantation can promote cardiac allograft tol-
erance across disparate MHC barriers. Across significant
MHC barriers, we believe that stronger initial immunosup-
pression will be required to prevent acute rejection of the
thymus and to permit its tolerogenic function. The en-bloc
technique described here will also require validation in a
nonhuman primate model because thymic anatomy in pri-
mates is slightly different. Our preliminary experiments
suggest that primate thymic vasculature does not preclude
application of the en-bloc technique.
Heart and en-bloc thymus transplantation supersedes our
previous method for transplantation of vascularized thymus,
which required a 2- to 3-month waiting period to allow
autologous thymic tissue fragments to become engrafted
under the donor heart epicardium.15 Not only does the
en-bloc technique allow much more vascularized donor
thymus to be conferred to the recipient at the time of organ
transplantation, but it also eliminates the 2- to 3-month
period of thymic engraftment. Thus this new technique
makes the transfer of large amounts of vascularized donor
thymus feasible in human recipients of cadaveric donor
hearts, with minimal modification of current operative and
immunosuppressive regimens. Because of the process of
thymic involution, we believe that donor thymus cotrans-
plantation will be most applicable to pediatric and adoles-
cent transplant recipients. It also might have utility in car-
diac xenotransplantation.
We thank Drs Leguern and Huang for their critical review of
the manuscript, Ms Rebecca Hasse for her assistance in its prep-
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